Tomoyuki Sakai - Concepedia

Author

Tomoyuki Sakai

Kanazawa Medical University ORCID

Also Known As

Sakai, Tomoyuki, T Sakai, T. Sakai, Tomoyuki SAKAI, Tomoyuki Sakai

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Kanazawa Medical University Kyoto University Niigata University of Pharmacy and Medical and Life Sciences University of Tsukuba University of Toyama

About

Tomoyuki Sakai is an author at Kanazawa Medical University specializing in medicine, pathology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	385
2	Health Sciences	3	3	45
3	Engineering	2	2	34
4	Biology	2	2	43
5	Natural Sciences	1	1	30

Tomoyuki Sakai

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version Yasufumi Masaki, Hiroshi Kawabata, Kazue Takai, International Journal of Hematology Tafro SyndromeMedicineDiagnosisPathologyDermatology	2016	199
Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease Yasufumi Masaki, Nozomu Kurose, Motohisa Yamamoto, International Journal of Rheumatology	2012	172
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, American Journal of Hematology	2019	100
Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^\|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity? Yasufumi Masaki, Akio Nakajima, Haruka Iwao, Journal of Clinical and Experimental Hematopathology	2013	91
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease Yasufumi Masaki, Shoko Matsui, Takako Saeki, Modern Rheumatology	2016	85
Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia. Toshihiro Fukushima, Hiroshi Kawabata, Takuji Nakamura, PubMed	2011	62
Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells Ziyi Jin, Chia‐Hui Huang, Lingli Dong, International Immunology	2008	58
Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-<i>Faslpr</i> Mice Yoshimasa Fujita, Takao Fujii, Tsuneyo Mimori, The Journal of Immunology ImmunologyImmune RegulationPathologyImmune DysregulationGastrointestinal Peptide Hormone	2014	50
Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan Shino Fujimoto, Hiroshi Kawabata, Tomoyuki Sakai, International Journal of Hematology Tafro SyndromeRetrospective Surveillance StudyDermatologyOptimal Treatments	2020	38
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice Lingli Dong, Ken Watanabe, M Itoh, International Immunology	2012	37

Page 1